These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21539943)

  • 1. Conformational, receptor interaction and alanine scan studies of glucose-dependent insulinotropic polypeptide.
    Venneti KC; Malthouse JP; O'Harte FP; Hewage CM
    Biochim Biophys Acta; 2011 Jul; 1814(7):882-8. PubMed ID: 21539943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR and alanine scan studies of glucose-dependent insulinotropic polypeptide in water.
    Alaña I; Parker JC; Gault VA; Flatt PR; O'Harte FP; Malthouse JP; Hewage CM
    J Biol Chem; 2006 Jun; 281(24):16370-6. PubMed ID: 16621806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide.
    Gault VA; Harriott P; Flatt PR; O'Harte FP
    Biosci Rep; 2002; 22(5-6):523-8. PubMed ID: 12635849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amide.
    Alaña I; Hewage CM; Malthouse JP; Parker JC; Gault VA; O'Harte FP
    Biochem Biophys Res Commun; 2004 Dec; 325(1):281-6. PubMed ID: 15522230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling.
    Malde AK; Srivastava SS; Coutinho EC
    J Pept Sci; 2007 May; 13(5):287-300. PubMed ID: 17437246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid.
    Green BD; Gault VA; Flatt PR; Harriott P; Greer B; O'Harte FP
    Arch Biochem Biophys; 2004 Aug; 428(2):136-43. PubMed ID: 15246869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations.
    Tikhele SH; Pissurlenkar RR; Srivastava S; Saran A; Coutinho EC
    J Pept Sci; 2010 Aug; 16(8):383-91. PubMed ID: 20607844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide.
    Hinke SA; Manhart S; Speck M; Pederson RA; Demuth HU; McIntosh CH
    Life Sci; 2004 Aug; 75(15):1857-70. PubMed ID: 15302229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide.
    Kerr BD; Flatt AJ; Flatt PR; Gault VA
    Biochem Biophys Res Commun; 2011 Jan; 404(3):870-6. PubMed ID: 21184739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis.
    Kim SJ; Choi WS; Han JS; Warnock G; Fedida D; McIntosh CH
    J Biol Chem; 2005 Aug; 280(31):28692-700. PubMed ID: 15955806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in vivo.
    Gault VA; O'Harte FP; Harriott P; Flatt PR
    Metabolism; 2003 Jun; 52(6):679-87. PubMed ID: 12800091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino terminal glycation of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cells.
    O'Harte FP; Abdel-Wahab YH; Conlon JM; Flatt PR
    Biochim Biophys Acta; 1998 Oct; 1425(2):319-27. PubMed ID: 9795247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide.
    Gault VA; O'Harte FP; Harriott P; Flatt PR
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1420-6. PubMed ID: 11820780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion.
    Ehses JA; Lee SS; Pederson RA; McIntosh CH
    J Biol Chem; 2001 Jun; 276(26):23667-73. PubMed ID: 11323439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand.
    Yaqub T; Tikhonova IG; Lättig J; Magnan R; Laval M; Escrieut C; Boulègue C; Hewage C; Fourmy D
    Mol Pharmacol; 2010 Apr; 77(4):547-58. PubMed ID: 20061446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16).
    Irwin N; Green BD; Parker JC; Gault VA; O'Harte FP; Flatt PR
    Regul Pept; 2006 Jul; 135(1-2):45-53. PubMed ID: 16675042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
    Pathak V; Vasu S; Flatt PR; Irwin N
    Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.
    Moon MJ; Kim HY; Kim SG; Park J; Choi DS; Hwang JI; Seong JY
    Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD; Gault VA; O'Harte FP; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.